These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1632312)

  • 1. Prostaglandin (PG) E1 and 13,14-dihydro (DH) PGE1 are diminishing radiation-induced arterial damage.
    Neumann I; Rogatti W; Virgolini I; Firbas W; Sinzinger H
    Agents Actions Suppl; 1992; 37():58-65. PubMed ID: 1632312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administration.
    Fitscha P; Rauscha F; Rogatti W; Peskar BA; O'Grady J; Sinzinger H
    Eicosanoids; 1991; 4(4):231-3. PubMed ID: 1789999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall.
    Rodrigues M; Sinzinger H; Kritz H; Peskar BA; O'Grady J; Rogatti W
    Vasa; 1995; 24(4):333-6. PubMed ID: 8533442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13,14-Dihydro-prostaglandin E1 decreases low-density lipoprotein influx into rabbit aorta.
    Sinzinger H; Virgolini I; Keiler A; Lupattelli G; Gerakakis A; Peskar BA
    Eur J Pharmacol; 1992 Aug; 219(1):129-33. PubMed ID: 1397039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
    Sinzinger H; Neumann I; O'Grady J; Rogatti W; Peskar BA
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):265-75. PubMed ID: 9653766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced mitotic activity induced by irradiation is abolished by PGI2 pretreatment.
    Sinzinger H; Zidek T; Rauscha F; Firbas W
    Prostaglandins; 1991 Jan; 41(1):57-65. PubMed ID: 2020746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
    Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW
    Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE1 reduces collagen and glycosaminoglycan synthesis in rabbit aorta.
    Sinzinger H; Zidek T; Rogatti W
    Exp Pathol; 1988; 33(2):119-22. PubMed ID: 3396651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitotic actions of vasodilatory prostaglandins--clinical aspects.
    Sinzinger H; Fitscha P; Kritz H
    Agents Actions Suppl; 1997; 48():92-106. PubMed ID: 9177101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of prostaglandin E₁ on radiation-induced proliferative inhibition and apoptosis in keratinocytes and healing of radiation-induced skin injury in rats.
    Takikawa M; Sumi Y; Tanaka Y; Nambu M; Doumoto T; Yanagibayashi S; Azuma R; Yamamoto N; Kishimoto S; Ishihara M; Kiyosawa T
    J Radiat Res; 2012; 53(3):385-94. PubMed ID: 22739008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
    Peskar BA; Cawello W; Rogatti W; Rudofsky G
    J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    Leonhardt A; Schweer H; Wolf D; Seyberth HW
    Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbits.
    Sinzinger H; Virgolini I; Li SR; Gerakakis A; Fitscha P; O'Grady J
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):503-6. PubMed ID: 7681515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation.
    Pallapies D; Peskar BA
    Thromb Res; 1993 Aug; 71(3):217-25. PubMed ID: 8211888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting depression of rabbit aortic prostacyclin formation by single-dose irradiation.
    Sinzinger H; Cromwell M; Firbas W
    Radiat Res; 1984 Mar; 97(3):533-6. PubMed ID: 6374740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostacyclin- and thromboxane synthesis in the vascular wall after gammatron irradiation].
    Sinzinger H; Cromwell M; Firbas W
    Strahlenther Onkol; 1986 Sep; 162(9):592-5. PubMed ID: 3532388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.